Selected article for: "art state and virus SARS"
Author: Di Gennaro, Francesco; Pizzol, Damiano; Marotta, Claudia; Antunes, Mario; Racalbuto, Vincenzo; Veronese, Nicola; Smith, Lee
Title: Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
  • Cord-id: u1k48t29
  • Document date: 2020_4_14
    • ID: u1k48t29
    Snippet: At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus a global pandemic. We performed a narrative review to describe existing literature with regard to Corona Virus Disease 2019 (COVID-19) epidemiology, pathophysiology, diagnosis, management and future perspective. MEDLINE, EMBASE and Scopus databases we
    Document: At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus a global pandemic. We performed a narrative review to describe existing literature with regard to Corona Virus Disease 2019 (COVID-19) epidemiology, pathophysiology, diagnosis, management and future perspective. MEDLINE, EMBASE and Scopus databases were searched for relevant articles. Although only when the pandemic ends it will be possible to assess the full health, social and economic impact of this global disaster, this review represents a picture of the current state of the art. In particular, we focus on public health impact, pathophysiology and clinical manifestations, diagnosis, case management, emergency response and preparedness.

    Search related documents:
    Co phrase search for related documents
    • abnormal mental status and low income: 1
    • acceptable alternative and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acceptable alternative and long short: 1
    • acceptable alternative and long short term: 1
    • acceptable alternative and lopinavir ritonavir: 1
    • acceptable alternative and low incidence: 1
    • acceptable alternative and low income: 1